There are still some debates regarding the definitive function of CD133 in GBM, but it is clear that the expression of CD133 may change due to several interactions with the tumor microenvironment, and may play a possible role in cell differentiation and the epithelial to mesenchymal transition (79). The gene discussed is PROM1; the disease is neoplasm.